|
Volumn 45, Issue 4, 2001, Pages 277-280
|
Pulmonary embolism diagnosis: What role for nuclear medicine?
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
ALGORITHM;
AWARENESS;
CAUSE OF DEATH;
CLINICAL FEATURE;
CLINICAL TRIAL;
COMORBIDITY;
COST EFFECTIVENESS ANALYSIS;
DEEP VEIN THROMBOSIS;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC TEST;
DIAGNOSTIC VALUE;
DISEASE PREDISPOSITION;
DISEASE SEVERITY;
EARLY DIAGNOSIS;
ECHOGRAPHY;
EDITORIAL;
FOLLOW UP;
HEALTH CARE ACCESS;
HEALTH CARE AVAILABILITY;
HEALTH PROMOTION;
HEART INFARCTION;
HUMAN;
INCIDENCE;
INTERMETHOD COMPARISON;
LUNG ANGIOGRAPHY;
LUNG CIRCULATION;
LUNG EMBOLISM;
LUNG PERFUSION;
LUNG SCINTISCANNING;
MEDICAL DECISION MAKING;
MORTALITY;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATIENT REFERRAL;
PRACTICE GUIDELINE;
PROGNOSIS;
RISK FACTOR;
SENSITIVITY AND SPECIFICITY;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
SPIRAL COMPUTER ASSISTED TOMOGRAPHY;
STROKE;
THROMBOEMBOLISM;
HUMANS;
LUNG;
PULMONARY EMBOLISM;
VENTILATION-PERFUSION RATIO;
|
EID: 0035563648
PISSN: 11243937
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (5)
|
References (16)
|